We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+14.34%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$546M
AUM Growth
+$146M
(+36%)
Cap. Flow
+$94.4M
Cap. Flow
% of AUM
17.28%
Top 10 Holdings %
Top 10 Hldgs %
77.86%
Holding
148
New
66
Increased
27
Reduced
14
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGU
Agrium
AGU
|
+$5.04M |
| 2 |
Dover
DOV
|
+$4.81M |
| 3 |
FedEx
FDX
|
+$4.81M |
| 4 |
Celanese
CE
|
+$4.28M |
| 5 |
Bunge Global
BG
|
+$3.93M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CADE
Cadence Bank
CADE
|
+$2.17M |
| 2 |
Huntington Bancshares
HBAN
|
+$2.12M |
| 3 |
Edwards Lifesciences
EW
|
+$1.82M |
| 4 |
M&T Bank
MTB
|
+$1.72M |
| 5 |
Biogen
BIIB
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 9.04% |
| 2 | Financials | 8% |
| 3 | Healthcare | 4.75% |
| 4 | Materials | 3.56% |
| 5 | Technology | 1.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
| $385M | 70.45% |
17,348,799
| – | – |
|
2
FNB Corp
FNB
$6.73B
| $5.72M | 1.05% |
385,000
+50,000
| +15% | +$768K |
|
|
3
FedEx
FDX
$72.7B
| $4.92M | 0.9% |
+25,200
| New | +$4.81M |
|
|
4
Dover
DOV
$27.6B
| $4.9M | 0.9% |
+75,518
| New | +$4.81M |
|
|
AGU
5
DELISTED
Agrium
AGU
| $4.78M | 0.87% |
+50,000
| New | +$5.04M |
|
|
6
Celanese
CE
$4.9B
| $4.4M | 0.8% |
+48,950
| New | +$4.28M |
|
|
7
Bunge Global
BG
$20.4B
| $4.15M | 0.76% |
+52,400
| New | +$3.93M |
|
|
WCN
8
Waste Connections
WCN
$42.2B
| $4.02M | 0.74% |
+68,363
| New | +$3.81M |
|
9
Associated Banc-Corp
ASB
$5.83B
| $3.9M | 0.71% |
160,000
+95,000
| +146% | +$2.39M |
|
10
KeyCorp
KEY
$24.2B
| $3.73M | 0.68% |
+210,000
| New | +$3.84M |
|
11
Truist Financial
TFC
$63.3B
| $3.67M | 0.67% |
82,000
+57,000
| +228% | +$2.66M |
|
12
US Bancorp
USB
$98.2B
| $3.6M | 0.66% |
70,000
+50,000
| +250% | +$2.67M |
|
|
PACW
13
DELISTED
PacWest Bancorp
PACW
| $3.52M | 0.64% |
66,000
-10,000
| -13% | -$548K |
|
14
Generac Holdings
GNRC
$11.6B
| $3.33M | 0.61% |
89,339
+58,716
| +192% | +$2.32M |
|
15
Regions Financial
RF
$26.4B
| $3.2M | 0.59% |
220,000
+100,000
| +83% | +$1.48M |
|
16
Herc Holdings
HRI
$5.02B
| $2.95M | 0.54% |
60,354
+39,938
| +196% | +$1.88M |
|
17
JetBlue
JBLU
$2.28B
| $2.88M | 0.53% |
+140,000
| New | +$2.85M |
|
18
Ashland
ASH
$3.33B
| $2.79M | 0.51% |
+45,990
| New | +$2.67M |
|
|
GCP
19
DELISTED
GCP Applied Technologies Inc.
GCP
| $2.62M | 0.48% |
80,099
+45,558
| +132% | +$1.32M |
|
20
Axalta
AXTA
$7.66B
| $2.58M | 0.47% |
+80,000
| New | +$2.38M |
|
21
Manitowoc
MTW
$497M
| $2.54M | 0.46% |
+111,251
| New | +$2.75M |
|
22
Western Alliance Bancorporation
WAL
$8.79B
| $2.5M | 0.46% |
51,000
+20,000
| +65% | +$1M |
|
|
EFII
23
DELISTED
Electronics for Imaging
EFII
| $2.46M | 0.45% |
50,430
+29,254
| +138% | +$1.35M |
|
24
Southwest Airlines
LUV
$22B
| $2.34M | 0.43% |
+43,500
| New | +$2.34M |
|
25
RB Global
RBA
$20.4B
| $2.3M | 0.42% |
+69,820
| New | +$2.26M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q1 2017 Portfolio in Review
As of Q1 2017, Crestline Management held 148 positions worth $546M, up 36% from $401M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Crestline Management deployed $94.4M of net new capital in Q1 2017, opening 66 new positions and adding to 27 existing holdings. Its largest new stake was Agrium: 50,000 shares worth $4.78M.
By sector, the portfolio is most concentrated in Industrials at 9% of assets, up from 2.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $1.25M trimmed.
- Crestline Management's largest Q1 2017 buy was Agrium: 50,000 shares worth $4.78M.
- Crestline Management added most to US Bancorp in Q1 2017, an estimated $2.67M increase.
- Crestline Management's biggest Q1 2017 reduction was Zimmer Biomet, cutting an estimated $1.25M.
- Crestline Management fully exited Cadence Bank in Q1 2017, selling an estimated $2.17M.
- Crestline Management's ten largest holdings make up 78% of its $546M portfolio in Q1 2017.
- Crestline Management opened 66 new positions and closed 36 in Q1 2017.
- Crestline Management's portfolio value rose 36% quarter-over-quarter to $546M.
Based on Crestline Management's 13F filing for Q1 2017, filed 12 May 2017.